AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29125384 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehabilitation exercise
Number of subjects: 0
Study 27209333 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobilization on the day of surgery
Number of subjects: 126
Study 27209333 — intervention group
Group type: COMPARATOR
Intervention: Mobilization on the day after surgery
Number of subjects: 126
Study 24625415 — intervention group
Group type: EXPERIMENTAL
Intervention: BCLU morphology
Number of subjects: 260
Study 24625415 — intervention group
Group type: EXPERIMENTAL
Intervention: MYC protein expression
Number of subjects: 260
Study 24625415 — intervention group
Group type: COMPARATOR
Intervention: Typical DLBCL morphology
Number of subjects: 260
Study 23237915 — intervention group
Group type: EXPERIMENTAL
Intervention: BungeeSkate training
Number of subjects: 20
Study 20056443 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency jet ventilation (HFJV)
Number of subjects: 40
Study 20056443 — intervention group
Group type: COMPARATOR
Intervention: Conventional one-lung ventilation (OLV) using double-lumen tubes (DLT)
Number of subjects: 40
Study 19539353 — intervention group
Group type: EXPERIMENTAL
Intervention: IA-BioHA (20 mg/2 ml)
Number of subjects: 588
Study 19539353 — intervention group
Group type: COMPARATOR
Intervention: IA-SA (buffered saline)
Number of subjects: 588
Study 19539353 — intervention group
Group type: COMPARATOR
Intervention: IA-BioHA vs IA-SA
Number of subjects: 588
Study 19539353 — intervention group
Group type: EXPERIMENTAL
Intervention: IA-BioHA
Number of subjects: 588
Study 19539353 — intervention group
Group type: COMPARATOR
Intervention: IA-SA
Number of subjects: 588
Study 16106139 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent without lesion predilation
Number of subjects: 0
Study 16106139 — intervention group
Group type: COMPARATOR
Intervention: Sirolimus-eluting stent after lesion predilation
Number of subjects: 0
Study 11844646 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive information on the importance of mobilization, balanced anesthesia, and postoperative analgesia including epidural local anesthetics and enforced postoperative mobilization
Number of subjects: 40
Study 11844646 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving anesthesia without epidural local anesthetics, postoperative analgesia with epidural morphine, and mobilization without fixed goals
Number of subjects: 40
Study 10069276 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil concentration of 1.5 ng/mL (group L)
Number of subjects: 39
Study 10069276 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil concentration of 3.0 ng/mL (group M)
Number of subjects: 39
Study 10069276 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil concentration of 4.5 ng/mL (group H)
Number of subjects: 39
Study 10069276 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil concentrations (all groups)
Number of subjects: 39
Study 10069276 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil concentration of 1.7 ng/mL
Number of subjects: 39
Study 7628181 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.03 mg/kg midazolam
Number of subjects: 12
Study 7628181 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.07 mg/kg midazolam
Number of subjects: 12
Study 7628181 — intervention group
Group type: COMPARATOR
Intervention: 0.1 mg/kg diazepam
Number of subjects: 12
Study 7628181 — intervention group
Group type: COMPARATOR
Intervention: 0.2 mg/kg diazepam
Number of subjects: 12
Study 2023732 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-vitrectomy
Number of subjects: 98
Study 2023732 — intervention group
Group type: COMPARATOR
Intervention: No vitrectomy (control)
Number of subjects: 98
Study 7034592 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg buflomedil
Number of subjects: 10
Study 7034592 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 10
Study 31858732 — intervention group
Group type: EXPERIMENTAL
Intervention: Large Changes (LC; lose 5-10 pounds initially)
Number of subjects: 599
Study 31858732 — intervention group
Group type: EXPERIMENTAL
Intervention: Small Changes (SC; make small daily changes in intake and activity)
Number of subjects: 599
Study 31858732 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 599
Study 31323662 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantable cardioverter-defibrillator (ICD)
Number of subjects: 1116
Study 28587607 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus feedback based on questionnaire results
Number of subjects: 150
Study 28587607 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 150
Study 25918933 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin (45 mg/day) for 14 days before surgery
Number of subjects: 0
Study 25918933 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 24983280 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 257
Study 24983280 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 257
Study 24983280 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 257
Study 24983280 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 257
Study 24983280 — intervention group
Group type: COMPARATOR
Intervention: Carbamazepine and Venlafaxine
Number of subjects: 257
Study 22017967 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (community-based group exercise sessions, instructed home exercise, dietary counselling)
Number of subjects: 190
Study 22017967 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 190
Study 19237785 — intervention group
Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 45
Study 19237785 — intervention group
Group type: COMPARATOR
Intervention: Two-stage adjustable suture technique
Number of subjects: 45
Study 19237785 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-stage adjustable strabismus surgery (SSASS) under topical anesthesia and intravenous conscious sedation
Number of subjects: 45
Study 17076222 — intervention group
Group type: EXPERIMENTAL
Intervention: Special exercise program (moderate exercise for maximum 1 hour 3 times a week for a year)
Number of subjects: 373
Study 17076222 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 373
Study 14660132 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone bolus administered under anaesthetic
Number of subjects: 48
Study 10783370 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol with water (group 1)
Number of subjects: 80
Study 10783370 — intervention group
Group type: COMPARATOR
Intervention: Misoprostol alone (group 2)
Number of subjects: 80
Study 10783370 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study 9032593 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole + recombinant human granulocyte colony stimulating factor (rhG‐CSF)
Number of subjects: 111
Study 9032593 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole monotherapy
Number of subjects: 111
Study 1355923 — intervention group
Group type: EXPERIMENTAL
Intervention: Idazoxan (20 mg, 40 mg, 80 mg)
Number of subjects: 0
Study 1355923 — intervention group
Group type: EXPERIMENTAL
Intervention: Yohimbine (20 mg)
Number of subjects: 0
Study 1355923 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6497745 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen sodium 0.03%
Number of subjects: 118
Study 6497745 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 118
Study 30146783 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrogen plasma treatment on one side of periorbital wrinkles with three sessions at a three-week interval
Number of subjects: 18
Study 30146783 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrogen plasma treatment
Number of subjects: 18
Study 30146783 — intervention group
Group type: COMPARATOR
Intervention: Control group (contralateral side without treatment)
Number of subjects: 18
Study 29743162 — intervention group
Group type: EXPERIMENTAL
Intervention: Short telomere length (measured ≤5 years before diagnosis)
Number of subjects: 788
Study 29743162 — intervention group
Group type: EXPERIMENTAL
Intervention: Short chromosome 5p telomere length
Number of subjects: 788
Study 29743162 — intervention group
Group type: EXPERIMENTAL
Intervention: Short chromosome 13q telomere length
Number of subjects: 788
Study 29743162 — intervention group
Group type: EXPERIMENTAL
Intervention: All-cause mortality patterns
Number of subjects: 788
Study 27701661 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA (200 U, cystoscopic intradetrusor injection)
Number of subjects: 381
Study 27701661 — intervention group
Group type: COMPARATOR
Intervention: Sacral neuromodulation
Number of subjects: 381
Study 27701661 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA
Number of subjects: 381
Study 25000668 — intervention group
Group type: EXPERIMENTAL
Intervention: Test dentifrice containing 1.5% arginine, an insoluble calcium compound and 1,450 ppm fluoride
Number of subjects: 48
Study 25000668 — intervention group
Group type: COMPARATOR
Intervention: Commercial silica dentifrice with 1,450 ppm fluoride as sodium fluoride (NaF)
Number of subjects: 48
Study 22174350 — intervention group
Group type: EXPERIMENTAL
Intervention: PACAP38 (10 pmol/kg/min for 20 minutes)
Number of subjects: 14
Study 22174350 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 22174350 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan (6 mg subcutaneously)
Number of subjects: 14
Study 20402845 — intervention group
Group type: COMPARATOR
Intervention: EMLA (for 60 min)
Number of subjects: 20
Study 20402845 — intervention group
Group type: EXPERIMENTAL
Intervention: Ametop (for 60 min)
Number of subjects: 20
Study 20402845 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapydan (for 30 min)
Number of subjects: 20
Study 17540991 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 76
Study 17540991 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole
Number of subjects: 76
Study 17540991 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 15802487 — intervention group
Group type: EXPERIMENTAL
Intervention: Context sensitive, visibly highlighted, selectable hyperlinks for educational decision support features
Number of subjects: 779
Study 15802487 — intervention group
Group type: COMPARATOR
Intervention: Standard CPOE interface with menu access to decision support
Number of subjects: 779
Study 11844821 — intervention group
Group type: EXPERIMENTAL
Intervention: Orally administered eniluracil and 5-FU (1.0 mg/m2 with eniluracil in a 10:1 ratio, twice daily for 28 days)
Number of subjects: 84
Study 10544991 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated drug and alcohol intervention (IDAI)
Number of subjects: 0
Study 10544991 — intervention group
Group type: COMPARATOR
Intervention: Minimal intervention condition (MI)
Number of subjects: 0
Study 8815652 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezoelectric lithotripter
Number of subjects: 18
Study 8815652 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrohydraulic lithotripter
Number of subjects: 18
Study 8815652 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 18
Study 1691416 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 0
Study 108739 — intervention group
Group type: EXPERIMENTAL
Intervention: Limbitrol
Number of subjects: 279
Study 108739 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 279
Study 108739 — intervention group
Group type: COMPARATOR
Intervention: Chlordiazepoxide
Number of subjects: 279
Study 30975525 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV10 (3+1 schedule, group A)
Number of subjects: 1201
Study 30975525 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV10 (3+0 schedule, group B)
Number of subjects: 1201
Study 30975525 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV10 (2+1 schedule, group C)
Number of subjects: 1201
Study 30975525 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV10 (two-dose schedule, group D)
Number of subjects: 1201
Study 30975525 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV13 (2+1 schedule, group E)
Number of subjects: 1201
Study 30975525 — intervention group
Group type: COMPARATOR
Intervention: No infant PCV (control, group F)
Number of subjects: 1201
Study 27753182 — intervention group
Group type: EXPERIMENTAL
Intervention: transdermal oestradiol (tE2)
Number of subjects: 727
Study 27753182 — intervention group
Group type: COMPARATOR
Intervention: luteinising hormone-releasing hormone agonists (LHRHa)
Number of subjects: 727
Study 24678746 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone iodine 2.5% solution irrigation
Number of subjects: 35
Study 24678746 — intervention group
Group type: COMPARATOR
Intervention: Preservative-free artificial tears and preservative-free antibiotic drops (without povidone iodine)
Number of subjects: 35
Study 23488588 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescents with psychopathic traits
Number of subjects: 35
Study 23488588 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 35
Study 21276812 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity Leaders (PALs) program
Number of subjects: 100
Study 19700221 — intervention group
Group type: EXPERIMENTAL
Intervention: Bondable reinforcement ribbon
Number of subjects: 25
Study 19700221 — intervention group
Group type: EXPERIMENTAL
Intervention: Light‐cured composite
Number of subjects: 25
Study 19700221 — intervention group
Group type: COMPARATOR
Intervention: Periodontal pack
Number of subjects: 25
Study 19700221 — intervention group
Group type: COMPARATOR
Intervention: Wire
Number of subjects: 25
Study 19700221 — intervention group
Group type: COMPARATOR
Intervention: Calcium hydroxide paste
Number of subjects: 25
Study 16371732 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy
Number of subjects: 6477
Study 16371732 — intervention group
Group type: COMPARATOR
Intervention: Open appendectomy
Number of subjects: 6477
Study 12972114 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 0
Study 12972114 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10713313 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.8 g eicosapentaenoic acid/d
Number of subjects: 224
Study 10713313 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.6 g docosahexaenoic acid/d
Number of subjects: 224
Study 10713313 — intervention group
Group type: COMPARATOR
Intervention: 4.0 g corn oil/d (placebo)
Number of subjects: 224
Study 8811760 — intervention group
Group type: EXPERIMENTAL
Intervention: General practice follow up
Number of subjects: 296
Study 8811760 — intervention group
Group type: COMPARATOR
Intervention: Hospital follow up
Number of subjects: 296
Study 1393483 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic appendicectomy
Number of subjects: 65
Study 1393483 — intervention group
Group type: COMPARATOR
Intervention: Open appendicectomy
Number of subjects: 65
Study 2867396 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral immunisation with killed Haemophilus influenzae
Number of subjects: 50
Study 2867396 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 31252161 — intervention group
Group type: EXPERIMENTAL
Intervention: Dawn-Dusk Simulator (DDS)
Number of subjects: 20
Study 31252161 — intervention group
Group type: COMPARATOR
Intervention: Control (no DDS)
Number of subjects: 20
Study 29280191 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplements (at least 50% of the recommended dose)
Number of subjects: 164
Study 29280191 — intervention group
Group type: COMPARATOR
Intervention: Nutritional supplements
Number of subjects: 164
Study 27594841 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Mandibular Advancement Splint (Twin-block)
Number of subjects: 16
Study 27594841 — intervention group
Group type: COMPARATOR
Intervention: Sham Mandibular Advancement Splint
Number of subjects: 16
Study 24853829 — intervention group
Group type: EXPERIMENTAL
Intervention: Serial clopidogrel dose adjustment based on platelet function testing (PFT) during 12 months of dual antiplatelet therapy (DAPT). Patients took up to two additional 600 mg loading doses and a maintenance dose of 75-300 mg.
Number of subjects: 87
Study 24853829 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard treatment without dose adjustment).
Number of subjects: 87
Study 24853829 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control).
Number of subjects: 87
Study 24853829 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventional group (with dose adjustment).
Number of subjects: 87
Study 22992417 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation salvage strategies used during the trial
Number of subjects: 0
Study 20562076 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 IU/kg heparin with an upper limit of 5,000 IU
Number of subjects: 162
Study 20562076 — intervention group
Group type: COMPARATOR
Intervention: 5,000 IU heparin (standard dose)
Number of subjects: 162
Study 20562076 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 IU/kg heparin
Number of subjects: 162
Study 17722960 — intervention group
Group type: COMPARATOR
Intervention: Intranasal fluticasone furoate 110 microg once daily for 2 weeks in adults and adolescents with seasonal allergic rhinitis
Number of subjects: 0
Study 17722960 — intervention group
Group type: COMPARATOR
Intervention: Intranasal fluticasone furoate 110 microg once daily for 4-6 weeks in adults and adolescents with perennial allergic rhinitis
Number of subjects: 0
Study 17722960 — intervention group
Group type: COMPARATOR
Intervention: Intranasal fluticasone furoate nasal spray in children aged 6-11 years for 2 weeks for seasonal allergic rhinitis
Number of subjects: 0
Study 17722960 — intervention group
Group type: COMPARATOR
Intervention: Intranasal fluticasone furoate nasal spray in children aged 6-11 years for 4 weeks for perennial allergic rhinitis
Number of subjects: 0
Study 17722960 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone furoate nasal spray in adults, adolescents and children aged 2-11 years
Number of subjects: 0
Study 15792815 — intervention group
Group type: EXPERIMENTAL
Intervention: 1500 mcg mecobalamin daily for 2 years
Number of subjects: 135
Study 15792815 — intervention group
Group type: COMPARATOR
Intervention: Untreated group (no mecobalamin)
Number of subjects: 135
Study 11865276 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextranomer/hyaluronic acid copolymer
Number of subjects: 61
Study 11865276 — intervention group
Group type: COMPARATOR
Intervention: Antibiotic prophylaxis
Number of subjects: 61
Study 11257272 — intervention group
Group type: EXPERIMENTAL
Intervention: CD14 C(‐260)T gene polymorphism
Number of subjects: 14916
Study 11257272 — intervention group
Group type: COMPARATOR
Intervention: Control group (age‐ and smoking‐matched participants who remained free of vascular diseases)
Number of subjects: 14916
Study 11367647 — intervention group
Group type: EXPERIMENTAL
Intervention: Xuefuzhuyu Pill (XFZYP) 6 g, three times daily for one month
Number of subjects: 57
Study 11367647 — intervention group
Group type: EXPERIMENTAL
Intervention: Xuefuzhuyu Pill (XFZYP)
Number of subjects: 57
Study 11367647 — intervention group
Group type: COMPARATOR
Intervention: Aspirin 40 mg per day for one month
Number of subjects: 57
Study 8158883 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 18
Study 8158883 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 18
Study 3142509 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil priming infusion (60 micrograms kg‐1 min‐1 for 10 min) followed by maintenance infusion (4.5 micrograms kg‐1 min‐1) with lorazepam 0.08 mg kg‐1 by mouth 1-2 h before operation.
Number of subjects: 19
Study 3142509 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil maintenance infusion rates of 5.4 (n = 4), 6.6 (n = 5), or 7.8 (n = 4) micrograms kg‐1 min‐1, each preceded by a proportional priming infusion with lorazepam 0.04 mg kg‐1 by mouth as premedication.
Number of subjects: 19
Study 29316106 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic-assisted radical cystectomy (RARC) with intracorporeal urinary diversion (ICUD)
Number of subjects: 39
Study 29316106 — intervention group
Group type: COMPARATOR
Intervention: Open radical cystectomy (ORC)
Number of subjects: 39
Study 29316106 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic-assisted radical cystectomy (RARC)
Number of subjects: 39
Study 28536866 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine-XR
Number of subjects: 90
Study 28536866 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 26209742 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthiest tertile of the modified Alternate Healthy Eating Index (mAHEI) score
Number of subjects: 3088
Study 26209742 — intervention group
Group type: EXPERIMENTAL
Intervention: Suboptimal dietary quality (mAHEI < 28) improved to mAHEI of 28
Number of subjects: 3088
Study 26209742 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 3088
Study 24278313 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivation session (MEG recording during imagery of maximum grips)
Number of subjects: 12
Study 24278313 — intervention group
Group type: COMPARATOR
Intervention: Control session (MEG recording during imagery of maximum grips)
Number of subjects: 12
Study 21176724 — intervention group
Group type: EXPERIMENTAL
Intervention: Erdosteine (E) 300 mg b.i.d. for 10 days
Number of subjects: 12
Study 21176724 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P) for 10 days
Number of subjects: 12
Study 18339162 — intervention group
Group type: COMPARATOR
Intervention: Propofol 1 mg/kg
Number of subjects: 47
Study 18339162 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 0.5 mg/kg and ketamine 0.5 mg/kg
Number of subjects: 47
Study 17162282 — intervention group
Group type: EXPERIMENTAL
Intervention: Crystalloid cardioplegia (Group 1)
Number of subjects: 40
Study 17162282 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood cardioplegia (Group 2)
Number of subjects: 40
Study 17162282 — intervention group
Group type: COMPARATOR
Intervention: Comparison of both groups
Number of subjects: 40